XBIT - XBiotech Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development14,94225,68341,72531,310
Selling General and Administrative6,0528,37611,0386,200
Non Recurring----
Others----
Total Operating Expenses20,99434,05952,76337,510
Operating Income or Loss-20,994-34,059-52,763-37,510
Income from Continuing Operations
Total Other Income/Expenses Net-144909227
Earnings Before Interest and Taxes-20,994-34,059-52,763-37,510
Interest Expense----
Income Before Tax-21,138-33,150-52,761-37,483
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-21,138-33,150-52,761-37,483
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-21,138-33,150-52,761-37,483
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-21,138-33,150-52,761-37,483